🔎 Trials Near Me

Hjem › Kardiovaskulær sygdom › Idaho

Kardiovaskulær sygdom kliniske forsøg i Idaho

4 studier for Kardiovaskulær sygdom søger deltagere på steder i Idaho.

Byer i Idaho

Officiel studietekst (engelsk)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Rocky Mountain Clinical Research - Idaho Falls, Idaho Falls
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

  • High Desert Heart & Vascular, Meridian
RekruttererFase 3
Alder 45 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07613294

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Meridian
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • St Lukes Idaho, Meridian
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.